Peter Salzmann, CEO, Director at Immunovant, holds 1.05M shares in Immunovant (Ticker: IMVT), holds ― shares in Corbus Pharmaceuticals (Ticker: CRBP). Most recently, Peter Salzmann Sold ― shares of Immunovant on Apr 19, 2024 for an estimated value of 990.27K.